SE0400708D0 - New compounds and use thereof - Google Patents

New compounds and use thereof

Info

Publication number
SE0400708D0
SE0400708D0 SE0400708A SE0400708A SE0400708D0 SE 0400708 D0 SE0400708 D0 SE 0400708D0 SE 0400708 A SE0400708 A SE 0400708A SE 0400708 A SE0400708 A SE 0400708A SE 0400708 D0 SE0400708 D0 SE 0400708D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
formula
cancer
preparing
Prior art date
Application number
SE0400708A
Other languages
English (en)
Swedish (sv)
Inventor
Jacob Westman
Klas Wiman
Galina Selivanova
Vladimir Bykov
Original Assignee
Aprea Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aprea Ab filed Critical Aprea Ab
Priority to SE0400708A priority Critical patent/SE0400708D0/xx
Publication of SE0400708D0 publication Critical patent/SE0400708D0/xx
Priority to SI200531186T priority patent/SI1727817T1/sl
Priority to DE602005023840T priority patent/DE602005023840D1/de
Priority to PT05722253T priority patent/PT1727817E/pt
Priority to EP05722253A priority patent/EP1727817B1/en
Priority to US10/590,054 priority patent/US7759361B2/en
Priority to CA2552855A priority patent/CA2552855C/en
Priority to AT05722253T priority patent/ATE482955T1/de
Priority to AU2005223728A priority patent/AU2005223728B2/en
Priority to ES05722253T priority patent/ES2349471T3/es
Priority to PCT/SE2005/000412 priority patent/WO2005090341A1/en
Priority to DK05722253.1T priority patent/DK1727817T3/da
Priority to JP2007504913A priority patent/JP4904561B2/ja
Priority to PL05722253T priority patent/PL1727817T3/pl
Priority to CY20101101187T priority patent/CY1111256T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE0400708A 2004-03-22 2004-03-22 New compounds and use thereof SE0400708D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof
PL05722253T PL1727817T3 (pl) 2004-03-22 2005-03-22 Pochodne azabicyklooktan-3-onu i ich zastosowanie
CA2552855A CA2552855C (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
AU2005223728A AU2005223728B2 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
PT05722253T PT1727817E (pt) 2004-03-22 2005-03-22 Derivados de azabiciclooctan-3-ona e seu uso
EP05722253A EP1727817B1 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
US10/590,054 US7759361B2 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
SI200531186T SI1727817T1 (sl) 2004-03-22 2005-03-22 Azabiciklooktan-3-onski derivati in njihova uporaba
AT05722253T ATE482955T1 (de) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivate und deren verwendung
DE602005023840T DE602005023840D1 (de) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivate und deren verwendung
ES05722253T ES2349471T3 (es) 2004-03-22 2005-03-22 Derivados de azabiciclooctan-3-ona y su uso.
PCT/SE2005/000412 WO2005090341A1 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
DK05722253.1T DK1727817T3 (da) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivativer og anvendelse heraf
JP2007504913A JP4904561B2 (ja) 2004-03-22 2005-03-22 アザビシクロオクタン−３−オン誘導体及びその使用
CY20101101187T CY1111256T1 (el) 2004-03-22 2010-12-23 Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof

Publications (1)

Publication Number Publication Date
SE0400708D0 true SE0400708D0 (sv) 2004-03-22

Family

ID=32067464

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof

Country Status (15)

Country Link
US (1) US7759361B2 (sl)
EP (1) EP1727817B1 (sl)
JP (1) JP4904561B2 (sl)
AT (1) ATE482955T1 (sl)
AU (1) AU2005223728B2 (sl)
CA (1) CA2552855C (sl)
CY (1) CY1111256T1 (sl)
DE (1) DE602005023840D1 (sl)
DK (1) DK1727817T3 (sl)
ES (1) ES2349471T3 (sl)
PL (1) PL1727817T3 (sl)
PT (1) PT1727817E (sl)
SE (1) SE0400708D0 (sl)
SI (1) SI1727817T1 (sl)
WO (1) WO2005090341A1 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062030A2 (en) * 2005-11-21 2007-05-31 Ohio University Quinuclidinone derivatives as anticancer agents
KR101727085B1 (ko) * 2010-01-21 2017-04-14 아프레아 에이비 과증식성 질환, 자가면역 질환 및 심장 질환을 치료하기 위한 3-퀴뉴클리디논을 포함하는 수용액
CN104860994A (zh) * 2014-02-20 2015-08-26 中国药科大学 3-奎宁环酮类含磷化合物的制备及其医药用途
WO2017159877A1 (en) * 2016-03-18 2017-09-21 Eisai R&D Management Co., Ltd. Use of eribulin and 3-quinuclidinone derivatives in the treatment of cancer
CN109280056A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 手性3-奎宁环酮类化合物、制备方法及用途
CN109280054A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 氘代3-奎宁环酮类化合物、制备方法及用途
JP2022500471A (ja) * 2018-09-20 2022-01-04 アプレア セラピューティクス アクティエボラーグ キヌクリジン−３−オン化合物および癌治療へのその使用
WO2021053155A1 (en) 2019-09-18 2021-03-25 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic bcl-2 family protein
WO2021170772A1 (en) 2020-02-26 2021-09-02 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of cd47 mediated signaling
WO2021180338A1 (en) 2020-03-09 2021-09-16 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of dna methyltransferase post stem cell transplant
WO2022175402A1 (en) 2021-02-18 2022-08-25 Aprea Therapeutics Ab Quinuclidine-3-one derivatives
WO2022204109A1 (en) * 2021-03-22 2022-09-29 Newave Pharmaceutical Inc. Quinuclidinone analogues as anticancer agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384641A (en) * 1967-09-19 1968-05-21 Aldrich Chem Co Inc 2-methylene-3-quinuclidones
US3726877A (en) * 1970-10-28 1973-04-10 Univ Temple Amine substituted methylene quinuclidone anti-bacterial agents
US4599344A (en) * 1984-10-31 1986-07-08 Schering A.G. Quinuclidines and quinuclidinium salts as antiarrhythmic agents
HUT62891A (en) * 1990-06-01 1993-06-28 Pfizer Process for producing 3-amino-2-arylquinuclidine compounds and pharmaceuticql composition comprising such compounds
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6500840B2 (en) * 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6921765B2 (en) * 2000-09-20 2005-07-26 Aprea Ab 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
US7659278B2 (en) 2002-02-21 2010-02-09 Aprea Ab Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
PL1605939T3 (pl) * 2003-03-24 2009-04-30 Aprea Ab Zastosowanie farmaceutyczne 1-azabicyklo[2.2.2]oktanów i sposób testowania zdolności związków do aktywowania nieaktywnego wt p53
SE0300812D0 (sv) 2003-03-24 2003-03-24 Karolinska Innovations Ab Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect

Also Published As

Publication number Publication date
DK1727817T3 (da) 2011-01-10
SI1727817T1 (sl) 2011-01-31
PT1727817E (pt) 2010-10-26
AU2005223728B2 (en) 2011-02-10
US20070142370A1 (en) 2007-06-21
AU2005223728A1 (en) 2005-09-29
CA2552855C (en) 2012-08-14
CA2552855A1 (en) 2005-09-29
PL1727817T3 (pl) 2011-03-31
DE602005023840D1 (de) 2010-11-11
EP1727817A1 (en) 2006-12-06
ES2349471T3 (es) 2011-01-03
CY1111256T1 (el) 2015-08-05
US7759361B2 (en) 2010-07-20
WO2005090341A1 (en) 2005-09-29
JP4904561B2 (ja) 2012-03-28
EP1727817B1 (en) 2010-09-29
JP2007530534A (ja) 2007-11-01
ATE482955T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
DK1727817T3 (da) Azabicyclooctan-3-onderivativer og anvendelse heraf
SE0200920D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
SE0102299D0 (sv) Compounds
SE0102300D0 (sv) Compounds
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200700225A1 (ru) Аналоги тетрапептида
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
TW200613243A (en) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
SE0300480D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
SE0401762D0 (sv) Novel compounds
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
UA85559C2 (en) Aminobenzophenone compounds
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
EP1817312A4 (en) MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease